Last year, Washington life science companies brought in $2.7 billion, and that’s not including public company financial transactions, which were huge.
“All signs point to another banner year in life science investing, particularly in areas of scientific research in which our region excels,” said Leslie Alexandre, president and CEO of Life Science Washington.
